Daily Archives: November 15, 2007

The FDA’s BTC Meeting

The FDA held an all day public meeting yesterday here in Washington to gain insight into the possibility of a Behind-the-Counter (BTC) designation for drugs.  BTC would be non-prescription, but would require the intervention of a learned intermediary – i.e., … Continue reading

Posted in FDA Policy | Comments Off on The FDA’s BTC Meeting